STATE STREET CORP - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 25 filers reported holding PSYCHEMEDICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q2 2023$73,699
-14.3%
16,1620.0%0.00%
Q1 2023$85,982
-46.2%
16,162
-50.0%
0.00%
Q4 2022$159,680
+53.5%
32,324
+100.0%
0.00%
Q3 2022$104,000
+2.0%
16,1620.0%0.00%
Q2 2022$102,000
-8.9%
16,1620.0%0.00%
Q1 2022$112,000
+1.8%
16,162
+1.9%
0.00%
Q4 2021$110,000
-18.5%
15,8620.0%0.00%
Q3 2021$135,000
+22.7%
15,8620.0%0.00%
Q2 2021$110,00015,8620.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 44,501$218,2630.12%
Cannell Capital 74,794$366,8420.07%
SANTA MONICA PARTNERS LP 20,000$980.07%
RBF Capital, LLC 144,231$707,0000.05%
CRAWFORD INVESTMENT COUNSEL INC 257,795$1,264,4050.03%
Ancora Advisors LLC 70,916$3480.01%
WEDBUSH SECURITIES INC 30,928$1520.01%
Renaissance Technologies 290,463$1,4250.00%
GEODE CAPITAL MANAGEMENT, LLC 35,206$1730.00%
NORTHERN TRUST CORP 17,030$83,5270.00%
View complete list of PSYCHEMEDICS CORP shareholders